Jain Global’s AbbVie ABBV Stock Holding History

Jain Global’s Portfolio ABBV Stock Details ABBV Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$30.2M	Buy	+138,687	New	+$30.8M	0.12%	146
2025 Q4	–	Sell	-23,477	Closed	-$5.44M	–	1189
2025 Q3	$5.44M	Buy	+23,477	New	+$4.78M	0.03%	336

Other funds holding ABBV

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

VPM

Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Jain Global's ABBV Position: Q1 2026 in Review

Jain Global opened a new position in AbbVie (ABBV) in Q1 2026: 138,687 shares worth $30.2M. The stake represents 0.12% of the portfolio and ranks #146 among its holdings. This is a return to the name: Jain Global previously reported a position in ABBV as recently as Q3 2025.

Jain Global first reported a position in ABBV in Q3 2025 and has held it in 2 quarters since. 4,080 funds tracked by Wall St. Rank hold ABBV as of Q1 2026.

Jain Global held 138,687 shares of AbbVie worth $30.2M as of Q1 2026.
AbbVie was a new Jain Global position in Q1 2026.
AbbVie made up 0.12% of Jain Global's portfolio in Q1 2026, its #146 holding.
Jain Global first reported a position in AbbVie in Q3 2025 and has held it in 2 quarters since.
4,080 funds tracked by Wall St. Rank held AbbVie as of Q1 2026.

Based on Jain Global's 13F filing for Q1 2026, filed 15 May 2026.